• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

健康人类血视网膜屏障的通透性。欧洲眼荧光测定法协同行动。

Permeability of the blood-retinal barrier in healthy humans. European Concerted Action on Ocular Fluorometry.

作者信息

Van Schaik H J, Heintz B, Larsen M, Leite E, Rosas V, Schalnus R, Van Best J A

机构信息

Department of Ophthalmology, Leiden University Medical Center, The Netherlands.

出版信息

Graefes Arch Clin Exp Ophthalmol. 1997 Oct;235(10):639-46. doi: 10.1007/BF00946940.

DOI:10.1007/BF00946940
PMID:9349948
Abstract

BACKGROUND

The aim of this study was to compare the inward permeability of the blood-retinal barrier in healthy subjects from six European cities.

METHODS

Seventy-two healthy subjects (age 20-70 years) were selected. At 30 min and 60 min after fluorescein injection, fluorescein mass in vitreous was calculated from the concentrations measured along the optical axis of the eye. Non-protein-bound fluorescein (NPBF) concentrations were measured in plasma prepared from blood samples taken 7, 15 and 55 min after injection. Blood-retinal barrier permeability (PBRB) was calculated from the vitreous fluorescein mass and the time integral of NPBF and was corrected for the autofluorescence of ocular tissue and for lenticular light transmittance.

RESULTS

Mean PBRB values +/- SD (nm.s-1) were 2.07 +/- 0.54 (Coimbra), 2.01 +/- 0.43 (Frankfurt), 2.24 +/- 0.50 (Ghent), 2.37 +/- 0.56 (Herlev), 1.89 +/- 0.44 (Leiden) and 1.74 +/- 0.38 (Porto). Differences between centers were not significant (P > 0.35). Measurements were reproducible and independent of the time after fluorescein injection (P > 0.50). A PBRB higher than 3.16 nm.s-1 or a value which had increased by 32% was considered abnormal (P < 0.05).

CONCLUSION

PBRB values were similar in all centers. The results demonstrate that this is a highly sensitive and reliable method for measuring the permeability of the blood-retinal barrier.

摘要

背景

本研究的目的是比较来自欧洲六个城市的健康受试者血视网膜屏障的内向通透性。

方法

选取72名健康受试者(年龄20 - 70岁)。在注射荧光素后30分钟和60分钟,根据沿眼光轴测量的浓度计算玻璃体内的荧光素质量。在注射后7分钟、15分钟和55分钟采集的血样制备的血浆中测量非蛋白结合荧光素(NPBF)浓度。根据玻璃体内荧光素质量和NPBF的时间积分计算血视网膜屏障通透性(PBRB),并对眼组织的自发荧光和晶状体透光率进行校正。

结果

各中心的平均PBRB值±标准差(nm·s⁻¹)分别为:科英布拉2.07±0.54、法兰克福2.01±0.43、根特2.24±0.50、赫勒夫2.37±0.56、莱顿1.89±0.44、波尔图1.74±0.38。各中心之间的差异不显著(P>0.35)。测量结果具有可重复性,且与荧光素注射后的时间无关(P>0.50)。PBRB高于3.16 nm·s⁻¹或升高32%的值被认为异常(P<0.05)。

结论

所有中心的PBRB值相似。结果表明,这是一种测量血视网膜屏障通透性的高度敏感且可靠的方法。

相似文献

1
Permeability of the blood-retinal barrier in healthy humans. European Concerted Action on Ocular Fluorometry.健康人类血视网膜屏障的通透性。欧洲眼荧光测定法协同行动。
Graefes Arch Clin Exp Ophthalmol. 1997 Oct;235(10):639-46. doi: 10.1007/BF00946940.
2
The blood-ocular barrier in type I diabetes without diabetic retinopathy: permeability measurements using fluorophotometry.无糖尿病视网膜病变的I型糖尿病患者的血-眼屏障:使用荧光光度法进行通透性测量。
Ophthalmic Res. 1995;27 Suppl 1:116-23. doi: 10.1159/000267856.
3
Effect of morphological abnormalities on blood retinal barrier permeability in diabetic retinopathy.形态学异常对糖尿病视网膜病变中血视网膜屏障通透性的影响。
Doc Ophthalmol. 1992;80(2):183-8. doi: 10.1007/BF00161244.
4
Diffusion coefficient through the blood-aqueous barrier using a standard protocol.使用标准方案测定的通过血-房水屏障的扩散系数。
Br J Ophthalmol. 1996 Apr;80(4):356-62. doi: 10.1136/bjo.80.4.356.
5
Mapping retinal fluorescein leakage with confocal scanning laser fluorometry of the human vitreous.通过共焦扫描激光荧光测定法绘制人玻璃体视网膜荧光素渗漏情况。
Arch Ophthalmol. 1999 May;117(5):631-7. doi: 10.1001/archopht.117.5.631.
6
Plasma fluorescein decay determination during fluorophotometry.荧光光度法中血浆荧光素衰减的测定
Doc Ophthalmol. 1987 Apr;65(4):403-22. doi: 10.1007/BF00143044.
7
Passive permeability and outward active transport of fluorescein across the blood-retinal barrier in early ARM.早期年龄相关性黄斑变性中荧光素跨血视网膜屏障的被动通透性和外向主动转运
Br J Ophthalmol. 2001 May;85(5):592-7. doi: 10.1136/bjo.85.5.592.
8
Estimation of permeability in blood-retinal barrier.血视网膜屏障通透性的评估。
Hokkaido Igaku Zasshi. 1990 Jul;65(4):419-27.
9
Fluorescein transport across the human blood-retina barrier in the direction vitreous to blood. Quantitative assessment in vivo.
Acta Ophthalmol (Copenh). 1994 Dec;72(6):655-62. doi: 10.1111/j.1755-3768.1994.tb04675.x.
10
Blood aqueous barrier permeability versus age by fluorophotometry.通过荧光光度法测定血-房水屏障通透性与年龄的关系。
Curr Eye Res. 1987 Jul;6(7):855-63. doi: 10.3109/02713688709034855.

引用本文的文献

1
Evaluation of diabetic retinopathy by fluorophotometry. European concerted action on ocular fluorometry.通过荧光光度法评估糖尿病视网膜病变。欧洲眼荧光测定法联合行动。
Int Ophthalmol. 1998;22(2):97-104. doi: 10.1023/a:1006132908679.

本文引用的文献

1
Blood-retinal barrier permeability and its relation to progression of retinopathy in patients with type 2 diabetes. A four-year follow-up study.2型糖尿病患者血视网膜屏障通透性及其与视网膜病变进展的关系。一项为期四年的随访研究。
Graefes Arch Clin Exp Ophthalmol. 1993 Mar;231(3):141-5. doi: 10.1007/BF00920936.
2
Permeability of the blood-ocular barrier in adolescent and adult diabetic patients.青少年及成年糖尿病患者血-眼屏障的通透性
Br J Ophthalmol. 1993 Mar;77(3):158-61. doi: 10.1136/bjo.77.3.158.
3
Clinical and metabolic factors associated with the blood retinal barrier permeability in insulin dependent diabetes mellitus without retinopathy.
Doc Ophthalmol. 1993;84(2):127-33. doi: 10.1007/BF01206247.
4
Permeability of the blood-retinal barrier and the blood-aqueous barrier in type I diabetes without diabetic retinopathy: simultaneous evaluation with fluorophotometry.1型糖尿病无糖尿病视网膜病变时血视网膜屏障和血房水屏障的通透性:荧光光度法同步评估
Ger J Ophthalmol. 1993 Aug;2(4-5):202-6.
5
An 18-month vitreous fluorophotometric follow-up study in juvenile diabetics.一项针对青少年糖尿病患者的为期18个月的玻璃体荧光光度随访研究。
Acta Ophthalmol (Copenh). 1993 Oct;71(5):651-6. doi: 10.1111/j.1755-3768.1993.tb04655.x.
6
The blood-retinal barrier in diabetes during puberty.青春期糖尿病患者的血视网膜屏障
Arch Ophthalmol. 1994 Oct;112(10):1334-8. doi: 10.1001/archopht.1994.01090220084027.
7
Effects of aldose reductase inhibition with tolrestat on diabetic retinopathy in a six months double blind trial.托瑞司他抑制醛糖还原酶对糖尿病视网膜病变影响的六个月双盲试验
Doc Ophthalmol. 1994;87(4):355-65. doi: 10.1007/BF01203344.
8
Fluorophotometric study of lens autofluorescence and the blood-retinal barrier in 56 diabetic patients.56例糖尿病患者晶状体自发荧光及血视网膜屏障的荧光光度研究。
Eur J Ophthalmol. 1995 Jan-Mar;5(1):13-8. doi: 10.1177/112067219500500103.
9
Fluorescein transport across the human blood-retina barrier in the direction vitreous to blood. Quantitative assessment in vivo.
Acta Ophthalmol (Copenh). 1994 Dec;72(6):655-62. doi: 10.1111/j.1755-3768.1994.tb04675.x.
10
Antihistamines reduce blood-retinal barrier permeability in type I (insulin-dependent) diabetic patients with nonproliferative retinopathy. A pilot study.抗组胺药可降低患有非增殖性视网膜病变的I型(胰岛素依赖型)糖尿病患者的血视网膜屏障通透性。一项初步研究。
Retina. 1995;15(2):134-40.